Swiss Biotech – Industry news, events, directory, Swiss Biotech Association

Swiss Biotech Ventures

The platform where global investors, industry partners and Swiss biotech ventures connect. — Create your free account today.

Learn more about the platform

The free platform operated by the Swiss Biotech Association grants access to all viable national and international investment firms and business leaders. Only projects based in Switzerland can be added.

Step-by-step guides

Industry

ten23 health & Becton Dickinson partner on full-service wearable injector commercialization

The partnership addresses growing demand for self-administered therapies with a scalable, ready-to-use injector platform.
January 20, 2026

FluoSphera: CHF 1.15m to scale human-based preclinical platform

The Swiss healthtech startup’s patented multi-tissue platform aims to make drug discovery faster, safer, and more human-relevant
January 19, 2026

Nouscom reports new findings on cancer interception

Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancers NOUS-209 is an off-the-shelf cancer immunotherapy designed to induce T cells against neoantigens present in tumors and precancer lesions in LS carriers Publication in Nature Medicine underscores significance of NOUS-209 clinical data and its innovative approach to inte
January 16, 2026

InterAx and Alveus: Strategic research and licensing agreement

InterAx Biotech Ltd (“InterAx”) and Alveus Therapeutics Inc. (“Alveus”) today announced a strategic research collaboration and licensing agreement to develop a differentiated small molecule candidate for metabolic disease to deliver durable weight loss with superior tolerability.
January 15, 2026

Xenometrix launches new kit for genotoxicity analysis

Xenometrix has launched the Rapid Micronucleus MoA (Mode of Action) Telomere Centromere Kit, a next-generation assay that accelerates and improves mechanistic genotoxicity analysis.
January 15, 2026

Report 2025

Released on May 5, 2025 at the Swiss Biotech Day 2025.

SIX Swiss Exchange talks to: Basilea on how it strengthened its market position in 2024

Christian Moser Nikles, Patent Expert & Christel Aebischer, Patent Expert | Swiss Federal Institute of Intellectual Property
SIX Swiss Exchange reviews publicly listed companies included in ‘Highlights of 2024: Year in Review’ (Pages 52 to 55). While Santhera and Kuros made good progress, SIX recognizes the notable success of Basilea which, 20 years after its IPO in 2004, has reported increasingly robust profits.
May 5, 2025

Building the future of healthcare: Switzerland’s key role in facilitating Johnson & Johnson’s global alliances

Sirpa Tsimal, Director Investment Promotion | Switzerland Global Enterprise
Switzerland Global Enterprise’s Sirpa Tsimal talks to Leila Schwery and Michael Hübner of Johnson & Johnson about the company’s commitment to fostering global partnerships, the evolution of its manufacturing and supply chain strategies, and the critical role Switzerland plays in shaping its global capabilities.
May 5, 2025

Working together towards a more innovation-friendly European biotech framework

Jan Lucht, Head Biotechnology | scienceindustries
Biotechnology applications are expanding globally into many areas beyond the pharmaceutical sector. A growing range of products meet consumer demands while contributing to sustainability and climate protection. However, the current European authorization process for these innovative products is unnecessarily burdensome and limits market access. Leading European business organizations have come tog
May 5, 2025

Success Stories

Presented each year at Swiss Biotech Day.

Dr. Pascale Vonmont

Winner in 2025

Dr. Dr. h.c. Henri B. Meier

Winner in 2025

FSRMM Fondation Suisse de Recherche sur les Maladies Musculaires

Winner in 2024

Talent Orbit

Our HR platform matches talent with opportunity.

Join SB Orbit today – it's free

Classic job listings

Get open positions seen by thousands.

Global Village

at the Swiss Biotech Day in Basel – May 4-5, 2026

The Global Village connects biotech and life sciences clusters worldwide. Join us — and over 3,000 senior experts from the life science industry.

Company Directory

Consultants

Consulting (370)

Producers

Products (602)

Agriculture (19) Cosmetics & fragrances (33) Diagnostics (123) Nutrition (human & animal) (40) Platform technologies (235) Therapeutics/vaccines (human) (350) Therapeutics/vaccines (veterinary) (45)

Service providers

Services (506)

Analytical tests & screening (114) Biochip/biosensors (36) Bioinformatics (96) Cell culture, cell technology (139) Contract manufacturing (82) Contract R&D (156) Laboratory equipment & devices (129) Medical devices/technologies (158) Production equipment (47) Reagents & (bio)chemicals (66)

Update your company listing

Log in — or — create a free account
Find you listing:
On the listing page: click on “Claim / update listing” (first-time update)
— or —
Click on the pencil icon next to the company name

Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members, the association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources.

Member benefits exclusive access and discounts

As a Swiss Biotech Association member, you profit from our engagement with national and international stakeholders, receive privileged information, share knowledge, improve your network and optimize business efficiency. Get more visibility and receive discounts at events, favorable rates with business solution providers and for promoting your company.